IL-6 expression by fibroblasts and myeloid cells in the tumor microenvironment has been implicated in PDAC development and tumor growth, progression, metastasis, drug resistance, and immune suppression (Holmer et al., 2014; Mace et al., 2018; Öhlund et al., 2017). The gene discussed is IL6; the disease is neoplasm.